Ithaca, NY, United States of America

Irene Alexandra Amaro

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Irene Alexandra Amaro

Introduction

Irene Alexandra Amaro is an accomplished inventor based in Ithaca, NY. She has made significant contributions to the field of biotechnology, particularly in the study of Huntington's disease. With a total of two patents to her name, her work focuses on innovative solutions to combat the effects of poly-glutamate protein aggregation.

Latest Patents

Irene's latest patents include "Single chain intrabodies that alter Huntingtin mutant degradation." This patent provides compositions and methods for intrabodies that bind and alter the effects of poly-glutamate protein aggregation in diseases associated with poly-glutamate, such as Huntington's disease. The intrabodies are designed to prevent poly-glutamate aggregation, gene dysregulation, and the negative effects associated with Huntington's disease.

Career Highlights

Irene is currently employed at Vybion, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against neurodegenerative diseases, and she is recognized for her innovative approaches in this challenging field.

Collaborations

Irene collaborates with various professionals in her field, including her coworker, Lee Alan Henderson. Their combined expertise contributes to the advancement of their research and the development of new therapeutic strategies.

Conclusion

Irene Alexandra Amaro's contributions to biotechnology and her innovative patents highlight her commitment to addressing critical health challenges. Her work continues to inspire advancements in the treatment of Huntington's disease and similar conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…